Comprendre les maladies infectieuses pour mieux les contrôler
Le Centre International de Recherche en Infectiologie (CIRI) est une unité mixte de l’Université Lyon 1, de l’Inserm, du CNRS et de l’ENS de Lyon, en partenariat avec VetAgro Sup, l'Institut Pasteur et les Hospices Civils de Lyon. Le CIRI rassemble des communautés de recherche scientifique et médicale d’horizons disciplinaires complémentaires regroupés en 3 spécialités qui travaillent ensemble avec pour objectif principal la compréhension des interactions entre les microbes et leurs hôtes afin de mieux lutter contre les maladies infectieuses.
- Three specialities working together
Mieux nous connaître
- Publications
-
Front. Immunol.: Longet S. and Paul S. https://www.frontiersin.org/articles/10.3389/fimmu.2023.1216402/full
- Vindry C, Guillin O, Wolff P, Marie P, Mortreux F, Mangeot PE, Ohlmann T, Chavatte L. Nucleic Acids Res. 2023 May 31:gkad482. doi: 10.1093/nar/gkad482.
-
Int. J. Mol. Sci.: Gabriel-Segard T., Rontard J., Miny L., Dubuisson L., Batut A., Debis D., Gleyzes M., François F., Larramendy F., Soriano A., Honegger T. and Paul S. https://www.mdpi.com/1422-0067/24/13/10568
-
Clinical Microbiology Reviews: Miguelena Chamorro B., De Luca K., Swaminathan G., Longet S., Mundt E., Paul S. https://journals.asm.org/doi/10.1128/cmr.00164-22
- Vaccines: Miguelena Chamorro B., De Luca K., Swaminathan G., Rochereau N., Majorel J., Poulet H. Chanut B., Piney L., Mundt E., Paul S. https://www.mdpi.com/2076-393X/11/5/982
- Legrand AF, Lucifora J, Lacombe B, Ménard C, Michelet M, Foca A, Abrial P, Salvetti A, Rivoire M, Lotteau V, Durantel D, André P, Ramière C. Hepatol Commun. 2023 Apr 14;7(5):e0078.
- Actualités
-
Le CIRI est représenté, ces mardi 23 et mercredi 24 mai 2023, au meeting du Réseau National des Hépatites virales qui se déroule à Paris.
-
CERP - Genomic information from Coronaviruses, like SARS-CoV-2, can be used to track the genetic evolution of the virus and study the correlation of new variants with the emergence of epidemiological waves. We developed a simple Machine Learning algorithm to define emerging variants in terms of clusters, based only on the spike protein information.
-
New publication - VIV Team in Nature communication
-
The planned appointment date will be halfway of 2022-2026, in order to prepare the candidate to take over the management of the Institute starting on 1st January 2027 for a first five-year term. The date of integration into the Institute, ideally mid-2024, should allow a strong involvement in the establishment of the preparation of the CIRI next term project and a transition period with the present Director, François-Loïc Cosset.
- Nous rejoindre
-
CERP - Genomic information from Coronaviruses, like SARS-CoV-2, can be used to track the genetic evolution of the virus and study the correlation of new variants with the emergence of epidemiological waves. We developed a simple Machine Learning algorithm to define emerging variants in terms of clusters, based only on the spike protein information.
-
The planned appointment date will be halfway of 2022-2026, in order to prepare the candidate to take over the management of the Institute starting on 1st January 2027 for a first five-year term. The date of integration into the Institute, ideally mid-2024, should allow a strong involvement in the establishment of the preparation of the CIRI next term project and a transition period with the present Director, François-Loïc Cosset.
- CERP - This will be a senior position at the recently created Center of Excellence in Respiratory Pathogens (CERP, https://ciri.ens-lyon.fr/cerp ) based in Lyon, France. The CERP develops evidence generating research to support decision making related to respiratory pathogens within the Civil Hospitals and the University Claude Bernard in Lyon. (...)
-
A 2-year post-doctoral position for a highly motivated and talented postdoctoral fellow is available in the team of Dr Marc Vocanson at the Centre International de Recherche en Infectiologie (CIRI), in Lyon, France.
-
Le candidat retenu travaillera dans le cadre d'un projet collaboratif JPIAMR DRUID (NOBACT) financé par l'ANR et portant sur l’évaluation de l’activité d’un nouvel antibiotique inhibiteur de CopA, une ATPase de type P transportant le cuivre, et identifier son impact sur la physiologie bactérienne.
- A post-doctoral position in Immuno-Therapy is open in EVIR Team
- Agenda
- " The origins of HIV-1 through the lens of host-virus interactions "
- "Yersinia species as model bacteria to study host/pathogen interactions & evolution"
- "The sources of antigenic peptides for the MHC class I pathway"
- "Decoding the battle between Mycobacterium tuberculosis and host metal defenses"
- " Scientific publishing at JEM: What, How and Why? "
- "Type I interferon exhaustion"